Philip Ron M bought AVTX
June 23, 2026 · Form 4 insider transaction
Philip Ron M bought 40,200 shares of Avalo Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,200
Price
$0.00
Total value
N/A
InsiderPhilip Ron M
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 23, 2026
Filing dateJune 25, 2026
Shares owned after40,200
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests in three substantially equal annual installments on the first, second and third anniversary of the date of grant, subject to the Eligible Director's continued service on each such vesting date.